Studies have shown SAD affects women four times more than men
Tirzepatide occupies the middle ground Tirzepatide, a dual GIP/GLP-1 receptor agonist, showed a reporting odds ratio of 1.73, elevated but lower than semaglutide
After three decades and more than two hundred papers, there is still no published randomized controlled trial showing efficacy
How Neurogan Health's GHK-Cu Serum Is Changing What Customers Expect From Hair Care While competitors fill bottles with 30 ingredients, customers using Neurogan's two-ingredient copper peptide serum are reporting visible hair changes and asking why no one did this sooner SAN DIEGO, April 28, 2026 /PRNewswire/ -- Neurogan Health set out to answer a simple question: how many ingredients does a hair serum actually need
modulating tissue-repair pathways
Again: DSIP is supportive it doesnt replace proper endocrine therapy or clinical intervention where needed